US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 1.850
  • +0.030+1.65%
Close Mar 25 16:00 ET
  • 1.850
  • 0.0000.00%
Post 16:00 ET
50.89MMarket Cap-2.20P/E (TTM)

About Immix Biopharma Company

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Company Profile

SymbolIMMX
Company NameImmix Biopharma
Listing DateDec 16, 2021
Issue Price5.00
Founded2012
CEODr. Ilya Rachman
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address11400 West Olympic Boulevard,Suite 200
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-651-8041

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vladimir Torchilin
  • Scientific Co-Founder
  • --
  • Dr. Ilya Rachman
  • Chairman of the Board and Chief Executive Officer
  • --
  • Dr. Graham Ross
  • Acting Chief Medical Officer and Head of Clinical Development
  • --
  • Gabriel Morris
  • Chief Financial Officer, Principal Accounting Officer and Director
  • --
  • Jason Hsu
  • Director
  • --
  • Helen C. Ada C.P.A.
  • Independent Director
  • --
  • Dr. Carey Ng
  • Independent Director
  • --
  • Yekaterina Chudnovsky
  • Independent Director
  • --
  • Jane M. Buchan, PhD
  • Independent Director
  • --
  • Dr. Magda Marquet, PhD
  • Independent Director
  • --
  • Nandan Oza
  • Head of Chemistry, Manufacturing, and Control
  • --

Market Insights

Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.

Unlock Now
Discussing
地產板塊回暖!中國資產能否延續漲勢?
3月17日早盤,地產代理、物業服務及管理等板塊漲幅明顯,貝殼-W早盤漲逾4%,碧桂園服務漲逾9%。政策消息面上,兩部門發文落實專項債支持收地,中房協組織民營房企座談會。中國資產本輪火爆行情還能持續多久?你會如何投資? Show More
focus on technology stocks
Top tech company strong as always.